Auransa to Participate in BioCentury-BayHelix China Healthcare Summit 2019
November 12, 2019 08:05 ET
|
Auransa
PALO ALTO, Calif., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Auransa, Inc., an artificial intelligence (AI)-driven pharmaceutical company developing precision medicines in areas of significant unmet medical...
Auransa Presents New Preclinical Data on AU-409, a Novel, AI-Derived Drug Candidate for the Treatment of Hepatocellular Carcinoma
September 23, 2019 08:05 ET
|
Auransa
PALO ALTO, Calif., Sept. 23, 2019 (GLOBE NEWSWIRE) -- Auransa Inc., an artificial intelligence (AI)-driven biotechnology company developing precision medicines in areas of significant unmet medical...
Auransa to Present New Data on AU-409, a Novel, AI-Generated Drug Candidate for the Treatment of Hepatocellular Carcinoma, at the 13th Annual Conference of the International Liver Cancer Association
September 16, 2019 08:05 ET
|
Auransa
PALO ALTO, Calif., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Auransa Inc., an artificial intelligence (AI)-driven biotechnology company developing precision medicines in areas of significant unmet medical...
Auransa Announces CEO to Participate on Executive Leadership Panel at the 6th Annual Indy Big Data Conference
September 12, 2019 08:05 ET
|
Auransa
PALO ALTO, Calif., Sept. 12, 2019 (GLOBE NEWSWIRE) -- Auransa Inc., an artificial intelligence (AI)-driven biotechnology company developing precision medicines in areas of significant unmet medical...
Auransa to Participate in BioCentury's 26th Annual Future Leaders in the Biotech Industry Conference
April 08, 2019 08:05 ET
|
Auransa
PALO ALTO, Calif., April 08, 2019 (GLOBE NEWSWIRE) -- Auransa Inc., an artificial intelligence (AI)-driven biotechnology company developing precision medicines in areas of significant unmet medical...
Auransa to Present at Biotech Showcase 2019
January 02, 2019 08:05 ET
|
Auransa
PALO ALTO, Calif., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Auransa Inc., an artificial intelligence (AI)-driven biotechnology company developing precision medicines in areas of significant unmet medical...
Auransa Enters into Exclusive Licensing Agreement with China Oncology Focus Limited, an Affiliate of Lee’s Pharmaceutical Holdings, for Rights to AU018 in Greater China and Southeast Asia
December 19, 2018 07:05 ET
|
Auransa
Auransa to Receive Upfront Payment and be Eligible for Milestone Payments and Sales Royalties for Preclinical Program Identified by Company’s AI-Driven SMarTR™ Engine China Oncology Focus to Receive...
Auransa to Participate in BioCentury-BayHelix China Healthcare Summit 2018
November 06, 2018 08:05 ET
|
Auransa
PALO ALTO, Calif., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Auransa, Inc., an artificial intelligence (AI)-driven pharmaceutical company developing precision medicines in areas of significant unmet medical...